Last reviewed · How we verify
Alanine, Dl- (DL-Alanine)
Alanine, Dl- (generic name: DL-Alanine) is a drug. It is currently in unknown development.
DL-Alanine is a non-essential amino acid that plays a role in various cellular processes, including protein synthesis and energy metabolism.
DL-Alanine is a small molecule compound with unknown target and drug class. Its original development and current ownership are not specified. The compound is not FDA-approved for any indications. As a result, there is limited information available on its commercial status, pharmacokinetics, or safety profile. Further research is needed to understand its potential therapeutic applications and risks.
At a glance
| Generic name | DL-Alanine |
|---|---|
| Therapeutic area | Metabolic |
| Phase | unknown |
Mechanism of action
In simple terms, DL-Alanine is an amino acid that helps build proteins and provides energy to cells. It's like a building block for the body's proteins and a source of fuel for cells to function properly. While it's not a medication in the classical sense, DL-Alanine may have therapeutic potential in certain conditions.
Approved indications
Common side effects
Key clinical trials
- Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD (PHASE2,PHASE3)
- FC Change From Day 1 to Day 3 Associated With SALD
- Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment (PHASE1)
- Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
- The Impact of the Distribution of Adipose Tissue on the Occurrence of Metabolic Disorders and the Level of Cardiopulmonary Fitness
- The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease
- The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries
- Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Alanine, Dl- CI brief — competitive landscape report
- Alanine, Dl- updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Alanine, Dl-
What is Alanine, Dl-?
How does Alanine, Dl- work?
What is the generic name of Alanine, Dl-?
What development phase is Alanine, Dl- in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing